These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

432 related items for PubMed ID: 15061993

  • 21. The clinical development of recombinant human interleukin 11 (NEUMEGA rhIL-11 growth factor).
    Kaye JA.
    Stem Cells; 1996; 14 Suppl 1():256-60. PubMed ID: 11012229
    [Abstract] [Full Text] [Related]

  • 22. Recombinant human thrombopoietin is an effective treatment for thrombocytopenia in hemophagocytic lymphohistiocytosis.
    Wang Y, Wang Z, Wu L, Zhang J, Wang J, Yan L.
    Ann Hematol; 2013 Dec; 92(12):1695-9. PubMed ID: 23778995
    [Abstract] [Full Text] [Related]

  • 23. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
    Liu Y, Jin G, Sun J, Wang X, Guo L.
    Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
    [Abstract] [Full Text] [Related]

  • 24. Recombinant human thrombopoietin improves platelet counts and reduces platelet transfusion possibility among patients with severe sepsis and thrombocytopenia: a prospective study.
    Wu Q, Ren J, Wu X, Wang G, Gu G, Liu S, Wu Y, Hu D, Zhao Y, Li J.
    J Crit Care; 2014 Jun; 29(3):362-6. PubMed ID: 24405656
    [Abstract] [Full Text] [Related]

  • 25. Effects of polyethylene glycol-conjugated recombinant human megakaryocyte growth and development factor on platelet counts after chemotherapy for lung cancer.
    Fanucchi M, Glaspy J, Crawford J, Garst J, Figlin R, Sheridan W, Menchaca D, Tomita D, Ozer H, Harker L.
    N Engl J Med; 1997 Feb 06; 336(6):404-9. PubMed ID: 9010146
    [Abstract] [Full Text] [Related]

  • 26. [Recombinant human interleukin-11 in the prevention of chemotherapy-induced thrombocytopenia].
    Chu DT, Xu BH, Song ST, Mao XH, Jiao SC, Zhang AL.
    Zhonghua Zhong Liu Za Zhi; 2003 May 06; 25(3):272-4. PubMed ID: 12839693
    [Abstract] [Full Text] [Related]

  • 27. [Efficacy of Recombinant Human Thrombopoietin and Recombinant Human Interleukin 11 for Treatment of Chemotherapy Indu-ced Thrombocytopenia in Acute Myeloid Leukaemia Patients].
    Tang G, Wang XM, Meng JX, Luan CL, Chen JF, Wu YQ, Zhang XN, He ZY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb 06; 26(1):234-238. PubMed ID: 29397850
    [Abstract] [Full Text] [Related]

  • 28. [Consensus on clinical diagnosis, treatment and prevention management of chemotherapy induced thrombocytopenia in China(2018)].
    Consensus Committee of Chemotherapy Induced Thrombocytopenia, Chinese Society of Clinical Oncology.
    Zhonghua Zhong Liu Za Zhi; 2018 Sep 23; 40(9):714-720. PubMed ID: 30293399
    [Abstract] [Full Text] [Related]

  • 29. A multicenter randomized controlled trial of recombinant human thrombopoietin treatment in patients with primary immune thrombocytopenia.
    Wang S, Yang R, Zou P, Hou M, Wu D, Shen Z, Lu X, Li Y, Chen X, Niu T, Sun H, Yu L, Wang Z, Zhang Y, Chang N, Zhang G, Zhao Y.
    Int J Hematol; 2012 Aug 23; 96(2):222-8. PubMed ID: 22753022
    [Abstract] [Full Text] [Related]

  • 30. Recombinant human thrombopoietin alleviates infection-associated thrombocytopenia: a retrospective study in senile patients.
    Lin J, Zhu H, Li S, Fan H, Lu X.
    Clin Appl Thromb Hemost; 2015 Jan 23; 21(1):19-24. PubMed ID: 23637005
    [Abstract] [Full Text] [Related]

  • 31. A real-world observation on thrombopoietic agents for patients with cancer treatment-induced thrombocytopenia in China: A multicenter, cross-sectional study.
    Chen M, Li L, Xia Q, Chen X, Liao Z, Wang C, Shen B, Zhou M, Zhang Q, Zhang Y, Qian L, Yuan X, Wang Z, Xue C, An X, Liu B, Gu K, Hou M, Wang X, Wang W, Li E, Zhong J, Cheng J, Shu Y, Yang N, Wang H, Yang R, Liu T, Deng T, Ma F, Liao W, Qiu W, Chen Y, Chen X, Zhang M, Xu R, Li X, Feng J, Ba Y, Shi Y.
    Cancer; 2024 Apr 15; 130(S8):1524-1538. PubMed ID: 38515388
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics and peripheral platelet counts after a single dose of recombinant human thrombopoietin in rhesus monkeys.
    Song HF, Liu XW, Tang ZM.
    Zhongguo Yao Li Xue Bao; 1999 Mar 15; 20(3):244-8. PubMed ID: 10452100
    [Abstract] [Full Text] [Related]

  • 33. Efficacy and safety of high dose recombinant human thrombopoietin in the treatment of immune thrombocytopenia.
    Wang X, Bi H, Liu L, Liu Y, Yin L, Yao J, Yu J, Tao W, Wei Y, Li Y, Yin L, Mu H, Du Y, Zhou Z.
    Platelets; 2023 Dec 15; 34(1):2271568. PubMed ID: 37941414
    [Abstract] [Full Text] [Related]

  • 34. Technology evaluation: thrombopoietin, Genentech/Pharmacia & Upjohn.
    Goldberg J.
    Curr Opin Mol Ther; 2000 Apr 15; 2(2):211-5. PubMed ID: 11249644
    [Abstract] [Full Text] [Related]

  • 35. [Effect of recombinant human interleukin 11 on the platelet after hematopoietic stem cell transplantation in patients with leukemia].
    Xu YJ, Chen FP, Li XL, Zhao XL, He Q.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Jun 15; 32(3):433-6. PubMed ID: 17611320
    [Abstract] [Full Text] [Related]

  • 36. [Thrombopoietic effect of recombinant human thrombopoietin gene transferred to mice mediated by electric pulse on normal and experimental thrombocytopenia mice].
    Zang W, Wei X, Wang S, Wang D.
    Zhonghua Xue Ye Xue Za Zhi; 2001 Mar 15; 22(3):128-31. PubMed ID: 11877062
    [Abstract] [Full Text] [Related]

  • 37. Phase I/II dose escalation study of recombinant human interleukin-11 following ifosfamide, carboplatin and etoposide in children, adolescents and young adults with solid tumours or lymphoma: a clinical, haematological and biological study.
    Cairo MS, Davenport V, Bessmertny O, Goldman SC, Berg SL, Kreissman SG, Laver J, Shen V, Secola R, van de Ven C, Reaman GH.
    Br J Haematol; 2005 Jan 15; 128(1):49-58. PubMed ID: 15606549
    [Abstract] [Full Text] [Related]

  • 38. Report: Heparin-induced thrombocytopenia associated with cardiopulmonary bypass: Preliminary attempt with recombinant human thrombopoietin therapy.
    Yuan SM.
    Pak J Pharm Sci; 2015 Sep 15; 28(5):1793-6. PubMed ID: 26408899
    [Abstract] [Full Text] [Related]

  • 39. The effect of recombinant human thrombopoietin (rhTPO) on sepsis patients with acute severe thrombocytopenia: a study protocol for a multicentre randomised controlled trial (RESCUE trial).
    Zhou Z, Feng T, Xie Y, Huang P, Xie H, Tian R, Qian B, Wang R.
    BMC Infect Dis; 2019 Sep 06; 19(1):780. PubMed ID: 31492102
    [Abstract] [Full Text] [Related]

  • 40. Recombinant human thrombopoietin (rhTPO) of different dosing regimens for refractory/relapsed primary immune thrombocytopenia: a multicenter, randomized controlled trial and pharmacokinetics study.
    Liu X, Bai Y, Wang T, Song Y, Sun F, Xia R, Zhu F, Ma J, Lu Q, Ye X, Zhan X, Li L, Guo X, Cheng S, Li Y, Guo Z, Chen Y, Qian S, Qin L, Zhang Q, Cao S, Yang R.
    Platelets; 2023 Dec 06; 34(1):2157806. PubMed ID: 36597010
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.